跳至主要内容
临床试验/DRKS00025278
DRKS00025278招募中不适用

Detection of calcitonin gene-related peptide (CGRP) in serum and tear fluid in headache associated with changes in CSF pressure or sinus vein thrombosis.

eurologie0 个研究点目标入组 200 人开始时间: 2021年6月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Inclusion Criteria for verum group
  • age over 18
  • german mother tongue
  • Headache associated with IIH or SIH or SVT
  • signed informed consent
  • Inclusion Criteria for controll group
  • age over 18
  • german mother tongue
  • max. of 2 days of not severe headache per month
  • no primary headache disorder (exception: episodic tension type headache)
  • signed informed consent

排除标准

  • Exclusion Criteria for verum group
  • other headache disorders (not episodic migraine or episodic tension type headache)
  • hypertension
  • CGRP (Receptor) antibodies in the last 3 months
  • severe psychiatric, endocrin
  • ological disorders, opththalmological disorders, contact lenses,
  • actual intake of triptans or other pain-medication in the last 48 hours before the visit (except vor SVT)
  • Exclusion Criteria controll group
  • BMI > 30 kg/m2
  • other headache disorders (not episodic migraine or episodic tension type headache)
  • hypertension
  • CGRP (Receptor) antibodies in the last 3 months
  • severe internal, neurological, psychiatric disorders,
  • actual intake of triptans or other pain-medication in the last 48 hours before the visit, Headache on the day of the examination

研究者

发起方
eurologie

相似试验